{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/336396830"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Accordingly, a patient's CD4 count typically is checked at care initiation, 3 months after beginning ART, and every 3 to 6 months thereafter; VL is measured within 2 to 4 weeks after ART initiation, every 4 to 8 weeks until VL suppression, and then every 3 to 4 months; and clinical outcomes, such as symptoms and OI development, are routinely monitored." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "uspharmacist.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/432825091"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/336396830"] } } }
